These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 9635243
1. Cefpirome: epidemiological survey in intensive care units and hematological units in The Netherlands. The Dutch Study Group. Hoogkamp-Korstanje JA, Verduyn Lunel F, Meis JF. Diagn Microbiol Infect Dis; 1998 Jul; 31(3):489-91. PubMed ID: 9635243 [No Abstract] [Full Text] [Related]
2. In vitro evaluation of cefpirome: an Australasian study of isolates from intensive care unit and hematology/oncology patients. The Cefpirome Study Group. Fernandes C, Pritchard R, Morris A, Benn R. Diagn Microbiol Infect Dis; 1998 Jul; 31(3):493-5. PubMed ID: 9635244 [No Abstract] [Full Text] [Related]
3. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group. Spencer RC. Scand J Infect Dis Suppl; 1993 Jul; 91():25-32. PubMed ID: 8290900 [Abstract] [Full Text] [Related]
4. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group. Verbist L. Scand J Infect Dis Suppl; 1993 Jul; 91():14-24. PubMed ID: 8290899 [Abstract] [Full Text] [Related]
7. [Multiresistant bacterial strains in infections of children treated at the National Research Institute of Mother and Child in 1999]. Drejewicz H, Toczynska B. Med Wieku Rozwoj; 2000 Jul; 4(4):431-9. PubMed ID: 11228601 [Abstract] [Full Text] [Related]
8. [Long term care units--nest of resistant bacteria?]. Laine J, Lumio J. Duodecim; 2005 Jul; 121(15):1679-81. PubMed ID: 16211842 [No Abstract] [Full Text] [Related]
10. Comparative in-vitro activity of cefpirome against isolates from intensive care and haematology/oncology units. Belgian Multicentre Study Group. Piérard D, Emmerechts K, Lauwers S. J Antimicrob Chemother; 1998 Apr; 41(4):443-50. PubMed ID: 9598775 [Abstract] [Full Text] [Related]
11. [Activity of cefpirome against bacteria isolated from hospitalized patients]. Fernández A, Herran I, de Mier C, Marcenac FM. Medicina (B Aires); 1989 Apr; 49(4):373-8. PubMed ID: 2487748 [Abstract] [Full Text] [Related]
13. Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients. Rolston K, Alvarez ME, Hoy JF, LeBlanc B, Ho DH, Bodey GP. Chemotherapy; 1986 Apr; 32(4):344-51. PubMed ID: 3731920 [Abstract] [Full Text] [Related]
17. [Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts]. Derevianko II, Kotliarova GA, Kondrat'eva EM, Khodyreva LA, Siniukhin VN. Antibiot Khimioter; 1996 Dec; 41(12):30-3. PubMed ID: 9124983 [Abstract] [Full Text] [Related]
18. In vitro activity of ceftobiprole against Gram-positive and Gram-negative bacteria isolated from humans and animals. Silva N, Radhouani H, Gonçalves A, Araújo C, Rodrigues J, Igrejas G, Poeta P. J Antimicrob Chemother; 2010 Apr; 65(4):801-3. PubMed ID: 20110342 [No Abstract] [Full Text] [Related]
19. [Results of a "round table" on cefpirome (Keiten)]. Navashin SM, Navashin PS. Antibiot Khimioter; 1996 Apr; 41(12):40-2. PubMed ID: 9124985 [No Abstract] [Full Text] [Related]
20. Use of very old and very new antibiotics in intensive care units in Germany. Meyer E, Schwab F, Gastmeier P. J Antimicrob Chemother; 2007 Dec; 60(6):1413-5. PubMed ID: 17951603 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]